Phase I clinical study of ecteinascidin-743 (ET-743) as a 24 hours continuous intravenous infusion (CI) in patients (pts) with solid tumors (st): A progress report

✍ Scribed by Taamma, A.; Cvilkovic, E.; Jimeno, J.; Gasparetto, M.; Meeley, K.; Vega, E.; Cameron, L.; Misset, J.L.

• Book ID: 122493501
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 404 KB
• Volume: 33
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(97)86029-7